Drugs / MF59-adjuvanted trivalent influenza vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01346592 Comparator | Apr 2011 → Jul 2012 | influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MF59-adjuvanted trivalent influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01346592 ↗ |
| Known as | aTIV | “MF59-adjuvanted trivalent subunit vaccine (aTIV)” PMID 25223266 ↗ Sep 2014 |
| Modality | Vaccine | “MF59-adjuvanted trivalent subunit vaccine (aTIV)” PMID 25223266 ↗ Sep 2014 |